T1	Outcomes 54 75	blood glucose control
T2	Outcomes 141 166	efficacy and tolerability
T3	Outcomes 788 837	postprandial glucose area under the curve AUC(0-2
T4	Outcomes 1033 1090	Postprandial AUC(0-2 h) of intact glucagon-like peptide-1
T5	Outcomes 1347 1359	Mean HbA(1c)
T6	Outcomes 1481 1496	DPP4 inhibition
T7	Outcomes 1639 1653	adverse events
T8	Outcomes 1851 1865	well tolerated
T9	Outcomes 1870 1901	improved blood glucose control.
